Hippocratic AI, a healthcare-focused generative AI startup, raised $141 million in a Series B financing round led by Kleiner Perkins, elevating its valuation to $1.64 billion and achieving “unicorn” status. The company develops AI agents for low-risk, non-diagnostic, patient-facing healthcare tasks to address global staffing shortages. Its AI-driven solutions, built on its safety-focused Polaris 2.0 architecture, have already signed contracts with 23 clients, including major health systems, and completed over 260,000 patient interactions with high satisfaction ratings. Hippocratic AI also introduced an AI agent app store, empowering clinicians to design, test, and monetize custom AI solutions, thereby extending the reach and effectiveness of healthcare services.
Founded by serial entrepreneur Munjal Shah alongside healthcare and AI experts, Hippocratic AI emphasizes safety, having achieved clinical safety parity for its agents with human clinicians. The company employs a rigorous three-phase testing process for its AI systems, involving thousands of licensed professionals. Its innovative approach to clinician-driven development allows experts to create and deploy AI agents across over 25 specialties, including maternal health and disaster preparedness. The newly secured funding will enable the company to expand into new markets, including Europe, Southeast Asia, and Latin America, while continuing to refine its AI agents and address critical healthcare challenges worldwide.